By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Over the last 12 months, three Volitionrx Ltd the people running the company bought shares in open-market trades, about $137,000 in total, and none of them sold.
Reynolds Cameron John (CEO) made the biggest buy, worth around $56,000. That includes C-suite money, which tends to get the most attention.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 4 of the last 7 full quarters. On the institutional side, 25 funds reported holding VNRX at the end of Q2 2026, and more funds bought than sold.
Are insiders buying or selling VNRX stock?
In the last 12 months Volitionrx Ltd insiders made open-market purchases worth about $137,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in VNRX?
The most recent open-market insider trade in VNRX was filed on 2025-11-17.
How many institutions own VNRX?
25 investment managers reported holding VNRX in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded VNRX?
No congressional trades in VNRX were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).